Guidelines Issued for Surgical Management of Chronic Rhinosinusitis in Adults
By Elana Gotkine HealthDay Reporter
MONDAY, June 2, 2025 -- In a new clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online May 27 in Otolaryngology-Head and Neck Surgery, recommendations are presented for the surgical management of chronic rhinosinusitis in adults.
Jennifer J. Shin, M.D., from Harvard Medical School in Boston, and colleagues developed 11 key action statements to aid clinicians in the surgical management of chronic rhinosinusitis in adults.
According to the guideline, the surgeon should verify an existing diagnosis of chronic rhinosinusitis before considering surgery. For an adult with chronic rhinosinusitis, the surgeon should not endorse or require a predefined regimen or duration of medical therapy as a prerequisite to sinus surgery. Patients who will benefit most from surgery and are least likely to benefit from continued medical therapy alone, such as those with chronic rhinosinusitis subtypes that include chronic rhinosinusitis with polyps, polyps with bony erosion, eosinophilic mucin, or fungal balls, should be identified.
The guideline authors also recommend establishing realistic expectations by counseling patients before surgery; these include the potential for chronicity or relapse and the likelihood of long-term medical management. The surgeon should obtain a computed tomography (CT) scan with a fine-cut protocol to examine the paranasal sinuses for surgical planning for an adult who is a candidate for surgery. The extent of surgery should not be planned solely based on arbitrary criteria regarding minimal level of mucosal thickening, sinus opacification, or outflow obstruction on CT scan. Adults who are scheduled for sinus surgery should be educated regarding anticipated postoperative care, including pain control.
"This clinical practice guideline provides the guidance for developing the needed care pathways for patients who may undergo surgery for chronic rhinosinusitis, based on current best evidence," Shin said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Nasal Endoscopic Surgery Beneficial for Chronic Sinusitis, Nasal Polyps
TUESDAY, May 6, 2025 -- For patients with chronic sinusitis and nasal polyps, nasal endoscopic surgery can remove polyps in a shorter time, with less intraoperative blood loss...
Baseline Characteristics ID Risk for Recurrent Endoscopic Sinus Surgery
THURSDAY, Feb. 6, 2025 -- A few baseline characteristics can predict the need for recurrent endoscopic sinus surgery (ESS) among patients with chronic...
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
WEDNESDAY, Sept. 18, 2024 -- Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b resectable nasal and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.